Home / business / AstraZeneca Sells Cholesterol Drug Rights To Grünenthal For $320 Million

AstraZeneca Sells Cholesterol Drug Rights To Grünenthal For $320 Million

-
AstraZeneca said on Tuesday it would sell rights to its cholesterol drug, Crestor, to German pharmaceutical company Grünenthal GmbH for an upfront payment of $320 million.

from Top Business News- News18.com
Read The Rest:timesnownews...
AstraZeneca Sells Cholesterol Drug Rights To Grünenthal For $320 Million AstraZeneca Sells Cholesterol Drug Rights To Grünenthal For $320 Million Reviewed by Team Exprssnews on November 30, 2020 Rating: 5

No comments:

Subscribe to: Post Comments ( Atom )
Powered by Blogger.